Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
71.88 CAD | +1.25% | -2.96% | +23.59% |
Apr. 15 | Morgan Stanley Raises Price Target on Ovintiv to $53 From $49, Keeps Equalweight Rating | MT |
Apr. 12 | Ovintiv Maintained at Buy at TPH Ahead of Q1 Results; Price Target at US$66.00 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.31% | 291B | |
+11.89% | 150B | |
+43.23% | 117B | |
+22.42% | 82.53B | |
+10.69% | 75.79B | |
+21.03% | 62.6B | |
+12.88% | 58.54B | |
+6.91% | 46.61B | |
-5.34% | 36.01B |
- Stock Market
- Equities
- OVV Stock
- OVV Stock
- News Ovintiv Inc.
- Scotiabank Upgrades Ovintiv to Sector Outperform from Sector Perform, Adjusts Price Target to $46 from $44